Author

Charmi Dipak Bhanushali

Observed names: C. Bhanushali, C.D. Bhanushali, CHARMI BHANUSHALI, Charmi Bhanushali

Observed institution: Saint Vincent Hospital

ORCID: 0009-0006-4527-8120

Observed ORCID: 0009-0006-4527-8120

OpenAlex ID: A5115009744

Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023

2025 · Mohsen Naghavi, Hmwe Hmwe Kyu, et al. · The Lancet · 693

PDF

Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023

2025 · Austin E Schumacher, Peng Zheng, et al. · The Lancet · 249

Leveraging beneficial microbiome-immune interactions via probiotic use in cancer immunotherapy

2025 · Chinmay T. Jani, Kyle Edwards, et al. · Frontiers in Immunology · 18

PDF

Hepatocellular carcinoma: A 30-year trend analysis of global burden stratified by risk factors, and socio-demographic indexes.

2025 · Charmi Bhanushali, Kalaivani Babu, et al. · Journal of Clinical Oncology · 5

PDF

Diagnostic Accuracy of a Large Language Model (ChatGPT-4) for Patients Admitted to a Community Hospital Medical Intensive Care Unit: A Retrospective Case Study

2025 · Jassimran Singh, Rhea Bohra, et al. · Journal of Intensive Care Medicine · 4

Chronic Myeloid Leukemia: Impact of Social and Demographic Disparities on Survival Outcomes

2024 · Vaibhavi P Mukhtiar, Om H Gandhi, et al. · Blood · 3

Clinical and Economic Burden of Paroxysmal Nocturnal Hemoglobinuria (PNH) in Hospitalized Patients: An Analysis of the 2021 NIS Database

2024 · Srinishant Rajarajan, Kalaivani Babu, et al. · Blood · 3

PDF

The economics of cancer immunotherapy: A five-year Medicare B expenditure analysis of checkpoint inhibitors.

2025 · Sharanya Tripathi, Charmi Bhanushali, et al. · Journal of Clinical Oncology · 2

PDF

Racial Inequities Influencing Admission, Disposition and Hospital Outcomes for Sickle Cell Anemia Patients: Insights from the National Inpatient Sample Database

2025 · Jayalekshmi Jayakumar, Nikhil Vojjala, et al. · Hematology Reports · 2

PDF

Biomarker Landscape of Antibody Drug Conjugates (ADCs) and Bispecific Antibodies in Clinical Trials for Lung Cancer

2024 · Madhan Srinivasan Kumar, Sameer Deshmukh, et al. · Clinical Lung Cancer · 2

IBCL-457: Non-Hodgkin B-Cell Lymphoma of the Face: A Population-Based Survival Analysis

2025 · Joao Pedro Thimotheo Batista, Charmi Dipak Bhanushali, et al. · Clinical Lymphoma Myeloma & Leukemia · 1

Incident reporting and outcomes of gastrointestinal adverse events with immune checkpoint inhibitors.

2025 · Nikhil Kumar Kotla, Charmi Bhanushali, et al. · Journal of Clinical Oncology · 1

PDF

Cardiac adverse events with PARP inhibitors: Real world pharmacovigilance study using FAERS database.

2025 · Lakshmi Kattamuri, Nikhil Vojjala, et al. · Journal of Clinical Oncology · 1

Tarlatamab-induced immune-related adverse events: Retrospective real-world pharmacovigilance study using FAERS database.

2025 · Nikhil Vojjala, Jayalekshmi Jayakumar, et al. · Journal of Clinical Oncology · 1

Hepatotoxic adverse events with immune checkpoint inhibitors: Real world pharmacovigilance study using FAERS database.

2025 · Panah Tushar Parab, Nikhil Vojjala, et al. · Journal of Clinical Oncology · 1

PDF

Breast cancer in chronic lymphocytic leukemia patients: Characteristics and survival outcomes.

2025 · Vidhi Bhanushali, Charmi Bhanushali, et al. · Journal of Clinical Oncology · 1

PDF

Racial and socioeconomic disparities in testicular cancer survival outcomes: A SEER database analysis.

2025 · Charmi Bhanushali, Raj N. Shah, et al. · Journal of Clinical Oncology · 1

PDF

Postpartum Breast Cancer in Young Women: A Biologically and Clinically Distinct Disease Entity

2025 · Charmi Bhanushali, Vidhi Bhanushali, et al. · Journal of young women's breast cancer and health. · 1

Demographic Analysis of Adult Patients with Disseminated Intravascular Coagulation (DIC) Admitted to Hospitals in 2021

2024 · Kalaivani Babu, Srinishant Rajarajan, et al. · Blood · 1

PDF

Trends in Multiple Myeloma Incidence and Mortality (1991-2021) in the United States: A Comprehensive Analysis of Gender and State-Level Disparities

2024 · Charmi Bhanushali, Vaibhavi Mukhtiar, et al. · Blood · 1

CAR-T Therapy Versus Bispecific Antibodies in Relapsed Refractory Multiple Myeloma: Systematic Review and Metanalysis of Toxicity and Response

2024 · Mansi Mehta, Devang Namjoshi, et al. · Blood · 1

PDF

Contemporary Patterns of Medicare Part B Spending on Immune Checkpoint Inhibitors (2018-2022)

2026 · Vidit Majmundar, Charmi Bhanushali, et al. · JCO Oncology Practice

Cardiac substructure dose signatures as predictors of late cardiovascular events in childhood cancer survivors.

2026 · Hrushikesh Reddy Pamreddy, Panah Tushar Parab, et al. · Journal of Clinical Oncology

Predictors of 30-day readmissions post-CAR-T in patients with relapsed/refractory multiple myeloma using the United States nationwide readmission database

2026 · Raj Shah, Nikhil Vojjala, et al. · Annals of Hematology

PDF

Early-onset prostate cancer: A time series analysis of age-stratified trends.

2026 · Charmi Bhanushali, Chinmay Jani, et al. · Journal of Clinical Oncology

Works count: 66

Citation count: 992

H-index: 4

I10-index: 3